ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2303

Emotional and Social Determinants of Health Increase Office Communication for Patients with Rheumatoid Arthritis

Dana DiRenzo1, Michael Wu 2, Thomas Grader-Beck 2, Susan J. Bartlett 3 and Clifton Bingham 1, 1Johns Hopkins University, Baltimore, MD, 2Johns Hopkins University, Baltimore, 3McGill University, Montreal, QC, Canada

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: quality of life and PROMIS, Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: RA – Diagnosis, Manifestations, & Outcomes Poster III: Comorbidities

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: In RA patients, anxiety and depression are associated with higher disease activity and worse outcomes. We hypothesized that in RA patients, poorer mental health would also be associated with more frequent office communication.

Methods: Charts of RA patients who received care at a university arthritis center for at least 1 year between April and September 2018 were identified from 530 records consecutively ordered by MRN (any arthritis type). Patients completed Patient Reported Outcome Measurement Information System (PROMIS) 29-item profiles (depression, anxiety, fatigue, physical function, pain interference, sleep disturbance, participation in social roles and activities) at an index care visit and phone calls and patient portal messages to rheumatologists and other providers were summed from the preceding 12 months.  Patients were stratified by telephone call volume (none vs >=1). Demographics, clinical characteristics, and frequency of communication were compared between groups using t-tests or chi-square; Poisson regression was used to evaluate the relationship between emotional distress and telephone frequency, controlling for age, sex, race, RA disease duration, clinical disease activity index (CDAI), and PROMIS physical function, social participation, sleep disturbance, pain interference, and fatigue. A sensitivity analysis was performed controlling for use of anti-depressants (AD) and benzodiazepines (BZD).

Results: 154 out of 185 RA patients met 2010 ACR criteria, completed PROMIS profiles, and had a complete CDAI; 1,452 office communications were accrued. Patients were mostly female (n=110, 71%) and white (n=109, 71%) with a mean age (SD) of 59 (14). The median RA disease duration (IQR) was 8 years (5, 16), and median CDAI (IQR) was low at 7.5 (4, 19). High anxiety was present in 24% of RA patients, and high depression symptoms in 18%. RA patients with >=1 versus no telephone calls were mostly female, tended to be older, have more disease activity, and take ADs (Table 1).  In multivariable Poisson regression, age (IRR=1.04, p< 0.01), race (IRR=1.75, p=< 0.01), social participation (IRR=0.95, p< 0.01), sleep disturbance (IRR=1.02, p=0.01), and anxiety (IRR=1.03, p< 0.01) were significantly associated with telephone call volume (any provider) (Table 2). Depression was associated with call volume in univariate analysis (IRR=1.04, p< 0.01) with a trend in multivariable analysis (IRR=0.98, p=0.06). In sensitivity analysis when controlling for use of AD and BZD, anxiety and depression continued to significantly impact call volume.

Conclusion: Office communication is driven by emotional and social determinants of health and not RA disease activity, duration, or disability. Patients with high anxiety or depression symptoms telephoned significantly more often than those with low symptoms, although this was not necessarily directed towards the rheumatologist. Early identification of anxiety and depression symptoms may prompt implementation of multi-modal strategies to address these symptoms and to provide additional information to alleviate patient concerns regarding their health. 


ACR Office Communication Abstract_Table 1


ACR Office Communication Abstract_Table 2


Disclosure: D. DiRenzo, None; M. Wu, None; T. Grader-Beck, None; S. Bartlett, Abbie, 2, Abbvie, 2, 5, Bayer, 5, International Society of QOL Research, 6, Janssen, 5, 8, Lilly, 5, Merck, 5, 8, Novartis, 5, 8, Pfizer, 5, Pfizer Inc, 8, PROMIS International, 6, UCB, 5, 8; C. Bingham, Abbvie, 5, AbbVie, 5, BMS, 2, 5, Bristol Meyer Squibb, 2, 5, Bristol Myers-Squibb, 2, 5, Bristol-Myers Squibb, 2, 5, Eli Lilly, 5, Eli/Lilly, 5, Genentech/Roche, 5, Janssen, 5, Janssen Research & Development, LLC, 2, Pfizer Inc, 5, Regeneron/Sanofi, 5, Sanofi/Regeneron, 5.

To cite this abstract in AMA style:

DiRenzo D, Wu M, Grader-Beck T, Bartlett S, Bingham C. Emotional and Social Determinants of Health Increase Office Communication for Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/emotional-and-social-determinants-of-health-increase-office-communication-for-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/emotional-and-social-determinants-of-health-increase-office-communication-for-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology